Overview

A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects

Status:
Completed

Trial end date:
2017-03-28

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate bioequivalence between the LCM tablet and syrup after single oral dosing in healthy Chinese male subjects.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma S.P.R.L.

Treatments:

Lacosamide